Search Results < Yale School of Medicine

171 results

News
Mutations Differ Across Younger and Older Breast Cancer Patients
Women younger than 40 years of age with advanced breast cancer often suffer from more aggressive disease and worse prognoses than their older counterparts. Knowing which types of genetic mutations these patients tend to have could inform treatment strategies and improve outcomes. In a new study, Yale Cancer Center researchers investigated the genomic alterations of patients with breast cancer, uncovering differences between younger and older patients.
3 Jun 2022
News
Uma Krishnamurti, MBBS, MD, PhD, Named New Director of Yale Breast Pathology
Uma Krishnamurti, MBBS, MD, PhD, Associate Professor of Pathology, has been named the new Director of Breast Pathology in the Department of Pathology at Yale School of Medicine, effective June 1.
31 May 2022
News
BRCA Experts Rally to Research DNA Repair for Better Breast, Ovarian and Other Cancer Treatments
A diverse team of BRCA gene experts work together to unlock the secrets of DNA repair and develop better breast, ovarian and other cancer treatments.
16 May 2022
News
Office Hours with… Maryam Lustberg
As director of the Breast Center at Smilow Cancer Hospital, Maryam Lustberg studies how to improve the quality of life of breast cancer patients. At home, she likes hanging out with her eight-year-old son. And at all times, she’s a big fan of coffee and sweets. We caught up with her for the latest edition of Office Hours, a Q&A series that introduces newcomers to the Yale faculty to the broader university community.
Source: Yale News
10 Jan 2022
News
Rimm Named Anthony N. Brady Professor of Pathology
David Rimm, MD, PhD, has been appointed the Anthony N. Brady Professor of Pathology
15 Dec 2021
News
Yale Scientists Reveal Molecular Pathway for Smarter Breast Cancer Drugs
New research at Yale has revealed major differences in aggressive types of breast cancer, and the potential for smarter treatments for patients. Triple-negative breast cancer, which has a low survival rate and a lack of helpful molecular biomarkers — specific proteins that signal the presence of disease — is among the most aggressive breast cancer subtypes.
Source: Yale West Campus News
17 Aug 2021
News
Meet Dr. Tara Sanft
Dr. Sanft explains her role as a breast medical oncologist, as well as Director of the Survivorship Clinic and Patient Experience Officer.
15 Jul 2021
News
Meet Dr. Rachel Greenup
Learn more about Dr. Rachel Greenup and her role as a breast cancer surgeon.
7 Jul 2021
News
Meet Dr. Andrea Silber
Dr. Andrea Silber discusses the team approach she uses to care for breast cancer patients as a medical oncologist, the important role of the caregiver, and her research into why certain populations are more prone to breast cancer.
28 Jun 2021
News
Meet Dr. Sarah Mougalian
Dr. Sarah Mougalian discusses her care of breast cancer patients and the importance of building a relationship with both her patients and their families, and how she helps them navigate the cancer journey.
16 Jun 2021
News
Diet and Exercise Are Winning Strategies for Breast Cancer Survivors
In a new study, researchers at the Yale School of Public Health have confirmed a winning strategy or breast cancer survivors: healthy eating and exercise.
18 Mar 2021
News
Dr. Mehra Golshan on the Need for Breast Cancer Screening and Warning Signs of the Disease
Dr. Mehra Golshan talks about the need for breast cancer screening and warning signs of the disease.
8 Oct 2020
News
Breast Density Laws Inform Mammogram Imaging
For many of the women who are scheduling the screening mammograms that were deferred in the spring, their health care decisions are being guided in part by knowledge gleaned from 10 years of dense breast notification laws.
9 Jul 2020
News
Yale Cancer Center Study Shows Immunotherapy Prior to Surgery May Help Destroy High-Risk Breast Cancer
A new study led by Yale Cancer Center (YCC) researchers shows women with high-risk HER2-negative breast cancer treated before surgery with immunotherapy, plus a PARP inhibitor with chemotherapy, have a higher rate of complete eradication of cancer from the breast and lymph nodes compared to chemotherapy alone.
27 Apr 2020
News
Yale findings expand understanding of fertility after chemotherapy
Women with a fairly common type of genetic mutation face a greater risk of infertility following chemotherapy for breast cancer, according to a new study from Yale fertility expert and scientist Dr. Kutluk Oktay.
31 Mar 2020
News
Breast Cancer Screening Costs High, Benefits Uncertain, for Women in 40s
There are substantial costs associated with breast cancer screenings for U.S. women in their 40s, a new Yale-led study finds, and these costs vary widely by region.
23 Mar 2020
News
Geneticist Sidi Chen Receives Large Award Which Will Further His Breast Cancer Work
This Department of Defense award goes to the “best and brightest in their fields,” and recognizes “creative and innovative individuals.” Investigators are chosen for their ability “to go beyond conventional thinking” in their respective areas of expertise.
4 Mar 2020
News
Breast Density Notification Laws not Effective for All Women
A new study suggests that state-mandated notifications on mammogram reports intended to inform women of the health risks related to breast density are not worded effectively.
9 Jan 2020
News
Sentinel Lymph Node Biopsy Provides no Benefit for Stage Zero Breast Cancer, Yale School of Public Health Study Finds
Older women with a very early, non-invasive breast cancer known as ductal carcinoma in situ (DCIS), gain no long-term benefit from undergoing a sentinel lymph node biopsy to see if the cancer has spread, new research by the Yale School of Public Health has found.
24 Oct 2019
News
Fighting for Hope: Breast Cancer Research at Yale
In honor of National Breast Cancer Awareness Month, YaleNews is highlighting stories of clinical breakthroughs by Yale doctors and scientists — and of a few of the courageous women who have taken on breast cancer personally.
Source: YaleNews
14 Oct 2019